Type(s) of biological therapy-Bevacizumab (Avastin) Posts on Medivizor
Navigation Menu

Type(s) of biological therapy-Bevacizumab (Avastin) Posts on Medivizor

Safety and patient-reported outcomes of atezolizumab with or without bevacizumab plus chemotherapy vs bevacizumab plus chemotherapy in non-small-cell lung cancer

Safety and patient-reported outcomes of atezolizumab with or without bevacizumab plus chemotherapy vs bevacizumab plus chemotherapy in non-small-cell lung cancer

Posted by on Sep 28, 2020 in Lung cancer | 0 comments

In a nutshell This study was conducted to assess the safety and patient reported outcomes (PRO) of the addition of atezolizumab (Tecentriq) to chemotherapy with and without bevacizumab (Avastin) vs bevacizumab plus chemotherapy in the treatment of nonsquamous non-small cell lung cancer (NSCLC). The addition...

Read More

Combo of taxane + bevacizumab + capecitabine is not recommended in metastatic breast cancer

Posted by on Feb 16, 2015 in Breast cancer | 0 comments

In a nutshell The authors studied the efficacy of taxanes (class of drugs including paclitaxel [Taxol] and docetaxel [Taxotere]) plus bevacizumab (Avastin) with or without capecitabine (Xeloda) in treating metastatic breast cancer.  Some background Bevacizumab has been studied for the treatment of breast cancer that is metastatic (that...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor